Alterations in Genes of the EGFR Signaling Pathway and Their Relationship to EGFR Tyrosine Kinase Inhibitor Sensitivity in Lung Cancer Cell Lines

Ítems similars

• MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors
  per: Kubo, Takafumi, et al.
  Publicat: (2009)
• Oncogene Mutations, Copy Number Gains and Mutant Allele Specific Imbalance (MASI) Frequently Occur Together in Tumor Cells
  per: Soh, Junichi, et al.
  Publicat: (2009)
• Ethnicity affects EGFR and KRAS gene alterations of lung adenocarcinoma
  per: SOH, JUNICHI, et al.
  Publicat: (2015)
• Lung Cancer Cell Lines as Tools for Biomedical Discovery and Research
  per: Gazdar, Adi F., et al.
  Publicat: (2010)
• PIK3CA Mutations and Copy Number Gains in Human Lung Cancers
  per: Yamamoto, Hiromasa, et al.
  Publicat: (2008)